EP2425824

EURO CELTIQUE
Application Number
EP11177516A
Filing Date
Apr 4, 2003
Status
Revoked
Feb 7, 2020
Grant Date
May 10, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP2425824B1 was granted to Euro Celtique on May 10, 2017 following the initial filing on Apr 4, 2003 under the application number EP11177516A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (11)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ZENTIVAFeb 9, 2018ADMISSIBLE
TEVA PHARMACEUTICALSFeb 8, 2018ADMISSIBLE
INTAS PHARMACEUTICALSFeb 5, 2018ADMISSIBLE
STADA ARZNEIMITTELJan 17, 2018ADMISSIBLE
G L PHARMANov 9, 2017ADMISSIBLE
ETHYPHARMNov 7, 2017ADMISSIBLE
ACINO PHARMAJul 3, 2017ADMISSIBLE
KRKAJun 9, 2017ADMISSIBLE
GLENMARK PHARMACEUTICALS EUROPEMay 29, 2017ADMISSIBLE
DEVELCO PHARMA SCHWEIZMay 11, 2017ADMISSIBLE
HEXAL SANDOZMay 11, 2017ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents